|
Compound abbreviations*
|
Monitoring Mode
|
Parent (m/z)
|
Product (m/z)
|
Tube lens (V)
|
Collision energy (eV)
|
Retention times (min)
|
|---|
|
CCS
|
[M + H]+
|
285.16
|
270.30
|
99
|
23
|
6.43
|
|
CCSG
|
[M + H]+
|
447.24
|
285.30
|
98
|
20
|
4.89
|
|
FAN
|
[M + H]+
|
623.44
|
381.40
|
130
|
40
|
4.89
|
|
PAL
|
[M + H]+
|
352.23
|
336.30
|
89
|
29
|
5.44
|
|
5-O-M
|
[M + H]+
|
453.27
|
291.30
|
108
|
22
|
6.01
|
|
ONO
|
[M + H]+
|
431.25
|
269.30
|
97
|
17
|
6.00
|
|
FOR
|
[M + H]+
|
269.20
|
197.30
|
97
|
34
|
7.32
|
|
AST-IV
|
[M + Na]+
|
807.53
|
627.40
|
221
|
49
|
8.69
|
|
BER
|
[M + H]+
|
336.19
|
320.28
|
94
|
30
|
5.38
|
- *The compound abbreviations and their associated terms:
- AST-IV: astragaloside IV; BER: berberine; CCS: calycosin; CCSG: calycosin-7-O-β-D- glucoside; FAN: fangchinoline; FOR: formononetin; ONO: ononin; PAL: palmatine; 5-O-M: 5-O-methylvisammioside.
